• NEW
    Blog
    July 29, 2026

    The pharmaceutical technology market is moving beyond point solutions. For years, providers competed by solving specific problems within individual parts of the value chain. Today, differentiation increasingly depends on how well those solutions can understand context,…
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Provider Recognition
    July 15, 2026

    Pharmaceutical enterprises are accelerating technology investments to modernize operations across the pharmaceutical value chain spanning drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. As AI, cloud, and data-driven capabilities become…
  • Life Sciences commercial teams have a familiar problem: every few years, the industry finds a new way to create fragmentation.  First came Customer Relationship Management (CRM) add-ons. Then omnichannel tools, content platforms, analytics dashboards, field enablement systems, event platforms,…
  • Blog
    July 10, 2026

    When an Artificial Intelligence (AI) system produces biased output, fails an audit, or triggers an unexpected action, accountability often fragments. Data governance teams point to the model. AI governance teams point to upstream data quality, lineage, or usage policies…
  • Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • State of the Market
    June 22, 2026

    Life sciences enterprises are rethinking Customer Relationship Management (CRM) services as commercial transformation becomes more complex, platform-driven, and outcome-focused. As organizations migrate to cloud-based CRM environments, expand their Veeva and Salesforce ecosystems, and navigate increasingly complex…
  • For years, life sciences commercial technology providers sold nouns. Customer Relationship Management (CRM). Analytics. Content. Events. Patient engagement. Next-best-action. Learning. Field enablement.  Each category had its own buyer, its own implementation partner, its own operating model, and often its own dashboard.…
  • A familiar pattern, at an unfamiliar speed  Technology has always reshaped the world, but never at the moment of invention. The steam engine, electricity, and the internet all took years, even decades, to transform economies. Their true impact emerged only once they were…
  • Blog
    May 05, 2026

    What is headless architecture and why is Salesforce pushing for it now? Salesforce’s push toward Headless 360 comes as the company closes the Fiscal Year (FY) 2026 from a position of strength, supported by US$41.5 billion…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Feb. 04, 2026

    As the Veeva ecosystem continues to expand rapidly - now representing a market of nearly $2 billion- life sciences organizations are rethinking how they approach Veeva-enabled transformation. What was once focused primarily on implementation is evolving…
  • Video
    Feb. 03, 2026

    As Veeva becomes the cornerstone of strategic transformation in life sciences, expectations from service providers are rapidly evolving. In this Q&A session, Chunky Satija, Vice President, and Rohit K, Practice Director, from Everest Group, discuss the…
  • Viewpoint
    Jan. 09, 2026

    As pharma enterprises modernize data architectures, automate workflows, and scale AI across the value chain, scientific expertise is becoming essential to realize meaningful outcomes from digital initiatives. Without scientific grounding, digital systems risk producing insights that…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • Thematic Report
    Dec. 24, 2025

    Enterprise AI is transitioning from experimentation to scaled deployment, as organizations focus on operationalizing AI through integrated technology stacks. As AI adoption deepens across business functions, enterprises are demanding comprehensive infrastructure and platform capabilities that support…
  • Voice of the Customer
    Dec. 18, 2025

    AI- and automation-enabled workflows, advanced data and analytics capabilities, and increasingly interoperable technology stacks are rapidly and meaningfully transforming the pharma platforms landscape. Together, these shifts are enabling greater efficiency, scalability, and agility across the biopharma…
  • Voice of the Partner
    Dec. 15, 2025

    Global technology ecosystems are rapidly transforming as enterprises increasingly rely on channel partners to deliver integrated, outcome-driven solutions. As technology stacks expand and customer expectations rise, technology providers are reshaping their partner engagement models to drive…
  • Tech Launch Perspective
    Dec. 05, 2025

    Salesforce continues to advance its enterprise AI agenda by extending agentic capabilities across its platform and embedding AI-driven automation into core and adjacent applications. This report evaluates Salesforce’s key product announcements at Dreamforce 2025, including the…

Items per page